APA

Scanvion Q., Béné J., Gautier S., Grandvuillemin A., Le Beller C., Chenaf C., Etienne N., Brousseau S., Cortot A. B., Mortier L., Staumont-Sallé D., Morschhauser F., Forestier A., Groh M., Launay D., Hachulla E., Labalette M., Kahn J. & Lefèvre G. (20210728). Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database. : Oncoimmunology.

Chicago

Scanvion Quentin, Béné Johana, Gautier Sophie, Grandvuillemin Aurélie, Le Beller Christine, Chenaf Chouki, Etienne Nicolas, Brousseau Solenn, Cortot Alexis B, Mortier Laurent, Staumont-Sallé Delphine, Morschhauser Franck, Forestier Alexandra, Groh Matthieu, Launay David, Hachulla Eric, Labalette Myriam, Kahn Jean-Emmanuel and Lefèvre Guillaume. 20210728. Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database. : Oncoimmunology.

Harvard

Scanvion Q., Béné J., Gautier S., Grandvuillemin A., Le Beller C., Chenaf C., Etienne N., Brousseau S., Cortot A. B., Mortier L., Staumont-Sallé D., Morschhauser F., Forestier A., Groh M., Launay D., Hachulla E., Labalette M., Kahn J. and Lefèvre G. (20210728). Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database. : Oncoimmunology.

MLA

Scanvion Quentin, Béné Johana, Gautier Sophie, Grandvuillemin Aurélie, Le Beller Christine, Chenaf Chouki, Etienne Nicolas, Brousseau Solenn, Cortot Alexis B, Mortier Laurent, Staumont-Sallé Delphine, Morschhauser Franck, Forestier Alexandra, Groh Matthieu, Launay David, Hachulla Eric, Labalette Myriam, Kahn Jean-Emmanuel and Lefèvre Guillaume. Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database. : Oncoimmunology. 20210728.